<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01631929</url>
  </required_header>
  <id_info>
    <org_study_id>65-HGNPE-2012</org_study_id>
    <nct_id>NCT01631929</nct_id>
  </id_info>
  <brief_title>Two Bag System for Hydration in Diabetes</brief_title>
  <official_title>Two Bag System vs. One Bag System for Hydration Patients With Diabetic Ketoacidosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General de Niños Pedro de Elizalde</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General de Niños Pedro de Elizalde</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial comparing the time needed to get the conditions to
      space hourly controls to controls every 4 hours, using the one bag system versus the two bags
      system, in the initial treatment of children with diabetic ketoacidosis. After fast infusion
      of isotonic saline solution (20 ml/kg) to prevent shock, the administration of maintenance
      fluids and insulin therapy is indicated. Hourly plasmatic levels of glucose controls could
      determine changes in glucose IV administration. On using the classic one bag system each
      change determine a bag change. Using the two bag system allows to deliver the patient the
      appropriate glucose infusion in less time.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The treatment of children with diabetic ketoacidosis includes fast infusion of isotonic
      saline solution to prevent shock (20 ml/kg), and then the administration of maintenance
      fluids and insulin therapy according to hourly plasmatic glucose levels controls. Finally,
      after patients stabilization, controls becomes less frequents (each 4 hours).

      During the stabilization period infusion of glucose is calculated hourly according to
      plasmatic glucose levels. These modifications in IV infusion can be very frequent, sometimes
      by the hour, requiring preparation of a new solution for hydration (in a new bag).

      This procedure takes time, during which the patient continues receiving the previous IV
      infusion until the changes are effectively made. Therefore, usually changes are not strictly
      hourly, interfering with the adjustment of the organism to the above mentioned changes.

      The 2 bag system consists in using 2 bags with different solutions with the same electrolyte
      content but different dextrose concentration (0% and 10%), administered simultaneously
      through the same intravenous line. Using this system allows that changes needed in the
      administration of fluids and/or dextrose, may be easily and instantly managed by delivering
      different amounts from each bag to achieve the desired infusion rate without having to
      replace the bag.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Monitoring Committee found significant &amp; meaningful difference on main outcome
  </why_stopped>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Achieve Patient Stabilization</measure>
    <time_frame>Participants were followed for the duration of ketoacidosis (an expected average of 12 hours)</time_frame>
    <description>Time needed to achieve patient stabilization defined by:
Plasmatic glucose &lt; 250 mg/dl
Blood pH &gt; 7.3
Plasmatic bicarbonate &gt; 15 mmol/L</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Diabetes</condition>
  <condition>Ketoacidosis</condition>
  <arm_group>
    <arm_group_label>One bag</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV infusion of fluids, electrolytes and dextrose using one bag</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two bags</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using 2 bags with different solutions with the same electrolyte content but different dextrose concentration (0% and 10%), administered simultaneously through the same intravenous line.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>One bag</intervention_name>
    <description>Infusion of dextrose and electrolytes using one bag</description>
    <arm_group_label>One bag</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Two bags</intervention_name>
    <description>Using 2 bags with different solutions with the same electrolyte content but different dextrose concentration (0% and 10%), administered simultaneously through the same intravenous line.</description>
    <arm_group_label>Two bags</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 1 to 18 years old

          -  Diabetic ketoacidosis(plasmatic glucose &gt; 250mg/dl, pH &lt; 7.3, bicarbonate &lt; 15mmol/L,
             ketonuria and glycosuria)

        Exclusion Criteria:

          -  Patients who already received insulin in the Emergency Department.

          -  Patients who, because of their clinical condition, require admission to intensive care
             unit.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan P Ferrira, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General de Niños Pedro de Elizalde</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital General de NIños Pedro de Elizalde</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1270AAN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <reference>
    <citation>Poirier MP, Greer D, Satin-Smith M. A prospective study of the &quot;two-bag system'' in diabetic ketoacidosis management. Clin Pediatr (Phila). 2004 Nov-Dec;43(9):809-13.</citation>
    <PMID>15583776</PMID>
  </reference>
  <results_reference>
    <citation>Grimberg A, Cerri RW, Satin-Smith M, Cohen P. The &quot;two bag system&quot; for variable intravenous dextrose and fluid administration: benefits in diabetic ketoacidosis management. J Pediatr. 1999 Mar;134(3):376-8.</citation>
    <PMID>10064682</PMID>
  </results_reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2012</study_first_submitted>
  <study_first_submitted_qc>June 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2012</study_first_posted>
  <results_first_submitted>August 19, 2015</results_first_submitted>
  <results_first_submitted_qc>September 23, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 26, 2015</results_first_posted>
  <last_update_submitted>December 19, 2016</last_update_submitted>
  <last_update_submitted_qc>December 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Ketoacidosis</keyword>
  <keyword>Children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketosis</mesh_term>
    <mesh_term>Acidosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>One Bag</title>
          <description>IV infusion of fluids, electrolytes and dextrose using one bag
One bag: Infusion of dextrose and electrolytes using one bag</description>
        </group>
        <group group_id="P2">
          <title>Two Bags</title>
          <description>Using 2 bags with different solutions with the same electrolyte content but different dextrose concentration (0% and 10%), administered simultaneously through the same intravenous line.
Two bags: Using 2 bags with different solutions with the same electrolyte content but different dextrose concentration (0% and 10%), administered simultaneously through the same intravenous line.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>One Bag</title>
          <description>IV infusion of fluids, electrolytes and dextrose using one bag
One bag: Infusion of dextrose and electrolytes using one bag</description>
        </group>
        <group group_id="B2">
          <title>Two Bags</title>
          <description>Using 2 bags with different solutions with the same electrolyte content but different dextrose concentration (0% and 10%), administered simultaneously through the same intravenous line.
Two bags: Using 2 bags with different solutions with the same electrolyte content but different dextrose concentration (0% and 10%), administered simultaneously through the same intravenous line.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="12"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.83" spread="1.7"/>
                    <measurement group_id="B2" value="9.67" spread="2.7"/>
                    <measurement group_id="B3" value="9.2" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Disease debuted</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to Achieve Patient Stabilization</title>
        <description>Time needed to achieve patient stabilization defined by:
Plasmatic glucose &lt; 250 mg/dl
Blood pH &gt; 7.3
Plasmatic bicarbonate &gt; 15 mmol/L</description>
        <time_frame>Participants were followed for the duration of ketoacidosis (an expected average of 12 hours)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>One Bag</title>
            <description>IV infusion of fluids, electrolytes and dextrose using one bag
One bag: Infusion of dextrose and electrolytes using one bag</description>
          </group>
          <group group_id="O2">
            <title>Two Bags</title>
            <description>Using 2 bags with different solutions with the same electrolyte content but different dextrose concentration (0% and 10%), administered simultaneously through the same intravenous line.
Two bags: Using 2 bags with different solutions with the same electrolyte content but different dextrose concentration (0% and 10%), administered simultaneously through the same intravenous line.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Achieve Patient Stabilization</title>
          <description>Time needed to achieve patient stabilization defined by:
Plasmatic glucose &lt; 250 mg/dl
Blood pH &gt; 7.3
Plasmatic bicarbonate &gt; 15 mmol/L</description>
          <units>Hours</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.3" lower_limit="10.5" upper_limit="16.1"/>
                    <measurement group_id="O2" value="9.8" lower_limit="8.64" upper_limit="10.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>One Bag</title>
          <description>IV infusion of fluids, electrolytes and dextrose using one bag
One bag: Infusion of dextrose and electrolytes using one bag</description>
        </group>
        <group group_id="E2">
          <title>Two Bags</title>
          <description>Using 2 bags with different solutions with the same electrolyte content but different dextrose concentration (0% and 10%), administered simultaneously through the same intravenous line.
Two bags: Using 2 bags with different solutions with the same electrolyte content but different dextrose concentration (0% and 10%), administered simultaneously through the same intravenous line.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ferreira Juan Pablo MD</name_or_title>
      <organization>HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE</organization>
      <phone>+5491136085959</phone>
      <email>ferreirajuanpablo@hotmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

